Status:
COMPLETED
The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis
Lead Sponsor:
Research Institute of Ophthalmology, Egypt
Conditions:
Infective Keratitis
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
This was a prospective, single centre, randomised controlled study to evaluate the clinical effectiveness of corneal collagen crosslinking as an adjuvant to antimicrobial therapy.
Detailed Description
This randomised controlled study of forty eyes of forty patients was conducted to assess the impact of corneal collagen crosslinking in addition to antimicrobial therapy. All forty patients presentin...
Eligibility Criteria
Inclusion
- • Patients presenting with infectious keratitis
Exclusion
- Infective keratitis \< 1mm from limbus
- Corneal thickness \< 350μm
- Previous herpetic eye disease
- Expectant and nursing women
Key Trial Info
Start Date :
May 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06967376
Start Date
May 21 2018
End Date
February 3 2022
Last Update
May 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Institute of Ophthalmology
Giza, Giza Governorate, Egypt
2
Research Institute of Ophthalmology
Giza, Egypt